| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |